Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena Schildgen

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|September 16, 2016
Routine molecular profiling of patients with NSCLCVerena Schildgen, Oliver Schildgen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2015
Respiratory Infections With Human BocavirusOliver Schildgen, Verena Schildgen
Seminars in Cancer Biology|November 21, 2018
The lonely driver or the orchestra of mutations? How next generation sequencing datasets contradict the concept of single driver checkpoint mutations in solid tumours - NSCLC as a scholarly exampleVerena Schildgen, Oliver Schildgen
Cancer|February 13, 2013
How is a molecular polymorphism defined?Verena Schildgen, Oliver Schildgen
Mbio|June 14, 2018
Reply to Liu et al., "Inability To Culture Pneumocystis jirovecii"Verena Schildgen, Oliver Schildgen
New Microbes and New Infections|June 6, 2022
Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)Verena Schildgen, Jessica Lüsebrink, Oliver Schildgen
Infection Control and Hospital Epidemiology|November 20, 2020
Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)Jessica Lüsebrink, Verena Schildgen, Oliver Schildgen
The Journal of Infection|December 27, 2022
Recommendation for broad use of Covid-19 mRNA vaccine boosters due to waning vaccine effectiveness is taking the easy way outVerena Schildgen, Jessica Lüsebrink, Oliver Schildgen
Expert Review of Anti-Infective Therapy|November 4, 2009
Novel therapies for an old virus: treatment of RSV infections in the 21st CenturyJessica Lüsebrink, Verena Schildgen, Oliver Schildgen
Experimental Hematology|March 31, 2011
Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changesVerena Schildgen, Michael Wulfert, Norbert Gattermann
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|September 16, 2016
Routine molecular profiling of patients with NSCLCVerena Schildgen, Oliver Schildgen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2015
Respiratory Infections With Human BocavirusOliver Schildgen, Verena Schildgen
Seminars in Cancer Biology|November 21, 2018
The lonely driver or the orchestra of mutations? How next generation sequencing datasets contradict the concept of single driver checkpoint mutations in solid tumours - NSCLC as a scholarly exampleVerena Schildgen, Oliver Schildgen
Cancer|February 13, 2013
How is a molecular polymorphism defined?Verena Schildgen, Oliver Schildgen
Mbio|June 14, 2018
Reply to Liu et al., "Inability To Culture Pneumocystis jirovecii"Verena Schildgen, Oliver Schildgen
New Microbes and New Infections|June 6, 2022
Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)Verena Schildgen, Jessica Lüsebrink, Oliver Schildgen
Infection Control and Hospital Epidemiology|November 20, 2020
Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)Jessica Lüsebrink, Verena Schildgen, Oliver Schildgen
The Journal of Infection|December 27, 2022
Recommendation for broad use of Covid-19 mRNA vaccine boosters due to waning vaccine effectiveness is taking the easy way outVerena Schildgen, Jessica Lüsebrink, Oliver Schildgen
Expert Review of Anti-Infective Therapy|November 4, 2009
Novel therapies for an old virus: treatment of RSV infections in the 21st CenturyJessica Lüsebrink, Verena Schildgen, Oliver Schildgen
Experimental Hematology|March 31, 2011
Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changesVerena Schildgen, Michael Wulfert, Norbert Gattermann
Pageof 8